Reference
Gossai N, et al. A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD). Bone Marrow Transplantation 49: 440-442, No. 3, Mar 2014 - USA
Rights and permissions
About this article
Cite this article
Clofarabine/cyclophosphamide/etoposide. Reactions Weekly 1548, 78 (2015). https://doi.org/10.1007/s40278-015-9901-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-9901-9